These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 17149715)

  • 1. A double-blind placebo-controlled trial of zonisamide (zonegran) in the treatment of essential tremor.
    Zesiewicz TA; Ward CL; Hauser RA; Sanchez-Ramos J; Staffetti JF; Sullivan KL
    Mov Disord; 2007 Jan; 22(2):279-82. PubMed ID: 17149715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A pilot, double-blind, placebo-controlled trial of pregabalin (Lyrica) in the treatment of essential tremor.
    Zesiewicz TA; Ward CL; Hauser RA; Salemi JL; Siraj S; Wilson MC; Sullivan KL
    Mov Disord; 2007 Aug; 22(11):1660-3. PubMed ID: 17580330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose-dependent safety and efficacy of zonisamide: a randomized, double-blind, placebo-controlled study in patients with refractory partial seizures.
    Brodie MJ; Duncan R; Vespignani H; Solyom A; Bitenskyy V; Lucas C
    Epilepsia; 2005 Jan; 46(1):31-41. PubMed ID: 15660766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zonisamide for essential tremor: an evaluator-blinded study.
    Handforth A; Martin FC; Kang GA; Vanek Z
    Mov Disord; 2009 Feb; 24(3):437-40. PubMed ID: 19117357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mirtazapine in essential tremor: a double-blind, placebo-controlled pilot study.
    Pahwa R; Lyons KE
    Mov Disord; 2003 May; 18(5):584-7. PubMed ID: 12722174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized, controlled clinical trial of zonisamide as adjunctive treatment for refractory partial seizures.
    Sackellares JC; Ramsay RE; Wilder BJ; Browne TR; Shellenberger MK
    Epilepsia; 2004 Jun; 45(6):610-7. PubMed ID: 15144425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zonisamide for essential tremor.
    Ondo WG
    Clin Neuropharmacol; 2007; 30(6):345-9. PubMed ID: 18090459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of zonisamide on essential tremor: a pilot crossover study in comparison with arotinolol.
    Morita S; Miwa H; Kondo T
    Parkinsonism Relat Disord; 2005 Mar; 11(2):101-3. PubMed ID: 15734668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pilot efficacy and tolerability: a randomized, placebo-controlled trial of levetiracetam for essential tremor.
    Handforth A; Martin FC
    Mov Disord; 2004 Oct; 19(10):1215-21. PubMed ID: 15390011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and tolerability of pregabalin in essential tremor: a randomized, double-blind, placebo-controlled, crossover trial.
    Ferrara JM; Kenney C; Davidson AL; Shinawi L; Kissel AM; Jankovic J
    J Neurol Sci; 2009 Oct; 285(1-2):195-7. PubMed ID: 19631949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topiramate in essential tremor: findings from double-blind, placebo-controlled, crossover trials.
    Connor GS; Edwards K; Tarsy D
    Clin Neuropharmacol; 2008; 31(2):97-103. PubMed ID: 18382182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carisbamate in essential tremor: brief report of a proof of concept study.
    Elble RJ; Biondi DM; Ascher S; Wiegand F; Hulihan J
    Mov Disord; 2010 Apr; 25(5):634-8. PubMed ID: 20201005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Zonisamide improves motor function in Parkinson disease: a randomized, double-blind study.
    Murata M; Hasegawa K; Kanazawa I;
    Neurology; 2007 Jan; 68(1):45-50. PubMed ID: 17200492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of a pelargonium sidoides preparation in patients with the common cold: a randomized, double blind, placebo-controlled clinical trial.
    Lizogub VG; Riley DS; Heger M
    Explore (NY); 2007; 3(6):573-84. PubMed ID: 18005909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized, double-blind, placebo-controlled study of guanfacine extended release in children and adolescents with attention-deficit/hyperactivity disorder.
    Biederman J; Melmed RD; Patel A; McBurnett K; Konow J; Lyne A; Scherer N;
    Pediatrics; 2008 Jan; 121(1):e73-84. PubMed ID: 18166547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levetiracetam is not effective for essential tremor.
    Elble RJ; Lyons KE; Pahwa R
    Clin Neuropharmacol; 2007; 30(6):350-6. PubMed ID: 18090460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Botulinum toxin type a prophylactic treatment of episodic migraine: a randomized, double-blind, placebo-controlled exploratory study.
    Aurora SK; Gawel M; Brandes JL; Pokta S; Vandenburgh AM;
    Headache; 2007 Apr; 47(4):486-99. PubMed ID: 17445098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of essential tremor with the barbiturate T2000 (1,3-dimethoxymethyl-5,5-diphenyl-barbituric acid).
    Melmed C; Moros D; Rutman H
    Mov Disord; 2007 Apr; 22(5):723-7. PubMed ID: 17265458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of amantadine in essential tremor: a randomized, placebo-controlled trial.
    Gironell A; Kulisevsky J; Pascual-Sedano B; Flamarich D
    Mov Disord; 2006 Apr; 21(4):441-5. PubMed ID: 16229019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized, double-blind, placebo-controlled study to evaluate botulinum toxin type A in essential hand tremor.
    Jankovic J; Schwartz K; Clemence W; Aswad A; Mordaunt J
    Mov Disord; 1996 May; 11(3):250-6. PubMed ID: 8723140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.